Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
EGenesis is a gene editing and genome engineering company developing human-compatible engineered organs to treat diseases.
IO Biotech is a clinical-stage biotech company developing disruptive immune therapies for the treatment of cancer.
PepGen is empowering nucleic acid therapeutics to go the distance.
HilleVax is a biopharmaceutical company that focuses on the development and commercialization of novel vaccines.
Allakos is a biotechnology company developing therapeutic antibodies targeting allergy, inflammatory and proliferative diseases.
ACELYRIN is a biopharma company that identifies, acquires, and accelerates the development and commercialization of life-changing therapies.
Seismic Therapeutic is a biotechnology company developing machine-learning technology for immunology drug development.
A private biopharmaceutical company .
Pathalys is a clinical biopharmaceutical company that develops therapeutics that improve late-stage chronic kidney disease.
Abata Therapeutics develops regulatory T cell (Treg) therapies for treating autoimmune diseases including progressive multiple sclerosis.
Prime Medicine is a biotechnology company that utilizes Prime Editing to modify genetic sequences to treat a wide range of diseases.
Claris Biotherapeutics develops biologic therapies for corneal diseases and other disorders affecting the ocular surface.
Clinical stage biotechnology company developing restorative treatments for people affected by neuropsychiatric & neuroimmunologic disorders
Gossamer Bio is a biopharmaceutical company focused on the discovery and development of novel and differentiated therapeutic products.
DELFI's AI platform uses whole-genome sequencing to detect cancer-associated cfDNA fragmentation patterns in the blood.
Jasper Therapeutics is a biotechnology company that develops novel antibody therapies for stem cell transplants.
LENZ Therapeutics operates as an organization engaged in the late-stage clinical development of pharmaceuticals for the eyes.
Neurogene is a developer of genetic medicines intended to improve patient outcomes for neurological disorders.
Septerna is a biotech firm unlocking diverse drug discovery potential in G protein-coupled receptors across various diseases.
Elevation Oncology is a clinical-stage biopharmaceutical company focused on the development of precision medicines for patients.
Upstream Bio focuses on developing an antibody therapy for the treatment of severe asthma.
Jade Biosciences is developing transformative therapies to redefine the standard of care for inflammation and immunology indications.
Mineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension.
MiroBio is Harnessing the natural control mechanisms of the immune system.
Samsara BioCapital has invested in 132 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Samsara BioCapital's top investment sectors include Biotechnology, Health Care, Therapeutics, Biopharma, Medical. The firm invests across 15 different industry categories.
Among tracked funding rounds, Mineralys Therapeutics received $500.0M in a Post-IPO Debt round. Samsara BioCapital's total known invested capital is $11.9B.
Samsara BioCapital's average investment size is $118.5M across its portfolio of 132 companies.
Recent Samsara BioCapital portfolio additions include EGenesis, IO Biotech, Pepgen, HilleVax, Allakos. These companies were founded in 2020 or later.